Skip to main content

Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression

Publication ,  Conference
Hwang, B-J; Tsao, L-C; Acharya, C; Trotter, T; Agarwal, P; Wang, T; Wei, J; Yang, X-Y; Lei, G-J; Osada, T; Lyerly, HK; Morse, MA; Hartman, Z
Published in: CANCER RESEARCH
2022

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2022

Volume

82

Issue

12

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hwang, B.-J., Tsao, L.-C., Acharya, C., Trotter, T., Agarwal, P., Wang, T., … Hartman, Z. (2022). Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. In CANCER RESEARCH (Vol. 82).
Hwang, Bin-Jin, Li-Chung Tsao, Chaitanya Acharya, Timothy Trotter, Pankaj Agarwal, Tao Wang, Junping Wei, et al. “Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression.” In CANCER RESEARCH, Vol. 82, 2022.
Hwang B-J, Tsao L-C, Acharya C, Trotter T, Agarwal P, Wang T, et al. Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. In: CANCER RESEARCH. 2022.
Hwang B-J, Tsao L-C, Acharya C, Trotter T, Agarwal P, Wang T, Wei J, Yang X-Y, Lei G-J, Osada T, Lyerly HK, Morse MA, Hartman Z. Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. CANCER RESEARCH. 2022.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2022

Volume

82

Issue

12

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis